Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Diplomat Pharmacy Inc. Expands Its Offerings


Diplomat Pharmacy Inc. Expands Its Offerings

Diplomat Pharmacy (NYSE: DPLO) continues to diversify away from being just a traditional specialty pharmacy, announcing the acquisition of National Pharmaceutical Services, a pharmacy benefit manager, in conjunction with its third-quarter earnings. Previous additions of specialty infusion and pharma services have already worked their way into the company's earnings, making up more than half of the company's EBITDA.

Metric

Q3 2017

Continue reading


Source: Fool.com

Diplomat Pharmacy Stock

€3.60
0.560%
The Diplomat Pharmacy stock is trending slightly upwards today, with an increase of €0.020 (0.560%) compared to yesterday's price.

Like: 0
Share

Comments